Literature DB >> 20554962

Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responses.

Murugesan V S Rajaram1, Michelle N Brooks, Jessica D Morris, Jordi B Torrelles, Abul K Azad, Larry S Schlesinger.   

Abstract

Mycobacterium tuberculosis enhances its survival in macrophages by suppressing immune responses in part through its complex cell wall structures. Peroxisome proliferator-activated receptor gamma (PPARgamma), a nuclear receptor superfamily member, is a transcriptional factor that regulates inflammation and has high expression in alternatively activated alveolar macrophages and macrophage-derived foam cells, both cell types relevant to tuberculosis pathogenesis. In this study, we show that virulent M. tuberculosis and its cell wall mannose-capped lipoarabinomannan induce PPARgamma expression through a macrophage mannose receptor-dependent pathway. When activated, PPARgamma promotes IL-8 and cyclooxygenase 2 expression, a process modulated by a PPARgamma agonist or antagonist. Upstream, MAPK-p38 mediates cytosolic phospholipase A(2) activation, which is required for PPARgamma ligand production. The induced IL-8 response mediated by mannose-capped lipoarabinomannan and the mannose receptor is independent of TLR2 and NF-kappaB activation. In contrast, the attenuated Mycobacterium bovis bacillus Calmette-Guérin induces less PPARgamma and preferentially uses the NF-kappaB-mediated pathway to induce IL-8 production. Finally, PPARgamma knockdown in human macrophages enhances TNF production and controls the intracellular growth of M. tuberculosis. These data identify a new molecular pathway that links engagement of the mannose receptor, an important pattern recognition receptor for M. tuberculosis, with PPARgamma activation, which regulates the macrophage inflammatory response, thereby playing a role in tuberculosis pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554962      PMCID: PMC3014549          DOI: 10.4049/jimmunol.1000866

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  75 in total

1.  Bacillus Calmette-Guérin induces the expression of peroxisome proliferator-activated receptor gamma in bladder cancer cells.

Authors:  Catalina Lodillinsky; María Sol Umerez; María Adela Jasnis; Alberto Casabé; Eduardo Sandes; Ana María Eiján
Journal:  Int J Mol Med       Date:  2006-02       Impact factor: 4.101

2.  Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8.

Authors:  J P Lynch; T J Standiford; M W Rolfe; S L Kunkel; R M Strieter
Journal:  Am Rev Respir Dis       Date:  1992-06

Review 3.  Peroxisome proliferator-activated receptors and inflammation.

Authors:  Leonardo A Moraes; Laura Piqueras; David Bishop-Bailey
Journal:  Pharmacol Ther       Date:  2005-09-15       Impact factor: 12.310

Review 4.  Cyclooxygenases and prostaglandins: shaping up the immune response.

Authors:  Bianca Rocca; Garret A FitzGerald
Journal:  Int Immunopharmacol       Date:  2002-04       Impact factor: 4.932

Review 5.  Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?

Authors:  C N Serhan
Journal:  Prostaglandins       Date:  1997-02

Review 6.  Inflammation, dyslipidaemia, diabetes and PPars: pharmacological interest of dual PPARalpha and PPARgamma agonists.

Authors:  P Gervois; J C Fruchart; B Staels
Journal:  Int J Clin Pract Suppl       Date:  2004-10

7.  Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma.

Authors:  Yasuharu Akasaki; Gentao Liu; Nancy H C Chung; Moneeb Ehtesham; Keith L Black; John S Yu
Journal:  J Immunol       Date:  2004-10-01       Impact factor: 5.422

Review 8.  C-type lectins and phagocytosis.

Authors:  Ann M Kerrigan; Gordon D Brown
Journal:  Immunobiology       Date:  2009-03-03       Impact factor: 3.144

9.  Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages.

Authors:  L S Schlesinger; S R Hull; T M Kaufman
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

10.  Transcriptional profiling of mycobacterial antigen-induced responses in infants vaccinated with BCG at birth.

Authors:  Helen A Fletcher; Alana Keyser; Mark Bowmaker; Peter C Sayles; Gilla Kaplan; Greg Hussey; Adrian V S Hill; Willem A Hanekom
Journal:  BMC Med Genomics       Date:  2009-02-24       Impact factor: 3.063

View more
  106 in total

Review 1.  Macrophage polarization in pathology.

Authors:  Antonio Sica; Marco Erreni; Paola Allavena; Chiara Porta
Journal:  Cell Mol Life Sci       Date:  2015-07-26       Impact factor: 9.261

Review 2.  The Minimal Unit of Infection: Mycobacterium tuberculosis in the Macrophage.

Authors:  Brian C VanderVen; Lu Huang; Kyle H Rohde; David G Russell
Journal:  Microbiol Spectr       Date:  2016-12

Review 3.  Host-directed therapeutics for tuberculosis: can we harness the host?

Authors:  Thomas R Hawn; Alastair I Matheson; Stephen N Maley; Omar Vandal
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

4.  NOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophages.

Authors:  Michelle N Brooks; Murugesan V S Rajaram; Abul K Azad; Amal O Amer; Martin A Valdivia-Arenas; Jong-Hwan Park; Gabriel Núñez; Larry S Schlesinger
Journal:  Cell Microbiol       Date:  2010-11-24       Impact factor: 3.715

Review 5.  Early clearance of Mycobacterium tuberculosis: a new frontier in prevention.

Authors:  Ayesha J Verrall; Mihai G Netea; Bachti Alisjahbana; Philip C Hill; Reimout van Crevel
Journal:  Immunology       Date:  2014-04       Impact factor: 7.397

Review 6.  Mannose-capped lipoarabinomannan in Mycobacterium tuberculosis pathogenesis.

Authors:  Joanne Turner; Jordi B Torrelles
Journal:  Pathog Dis       Date:  2018-06-01       Impact factor: 3.166

7.  Estrogen modulation of endosome-associated toll-like receptor 8: an IFNα-independent mechanism of sex-bias in systemic lupus erythematosus.

Authors:  Nicholas A Young; Lai-Chu Wu; Craig J Burd; Alexandra K Friedman; Benjamin H Kaffenberger; Murugesan V S Rajaram; Larry S Schlesinger; Hayley James; Margaret A Shupnik; Wael N Jarjour
Journal:  Clin Immunol       Date:  2014-01-24       Impact factor: 3.969

Review 8.  Advancing host-directed therapy for tuberculosis.

Authors:  Robert S Wallis; Richard Hafner
Journal:  Nat Rev Immunol       Date:  2015-03-13       Impact factor: 53.106

Review 9.  Defining a Research Agenda to Address the Converging Epidemics of Tuberculosis and Diabetes: Part 2: Underlying Biologic Mechanisms.

Authors:  Katharina Ronacher; Reinout van Crevel; Julia A Critchley; Andrew A Bremer; Larry S Schlesinger; Anil Kapur; Randall Basaraba; Hardy Kornfeld; Blanca I Restrepo
Journal:  Chest       Date:  2017-04-20       Impact factor: 9.410

10.  Characterization of lung inflammation and its impact on macrophage function in aging.

Authors:  Cynthia H Canan; Nandan S Gokhale; Bridget Carruthers; William P Lafuse; Larry S Schlesinger; Jordi B Torrelles; Joanne Turner
Journal:  J Leukoc Biol       Date:  2014-06-16       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.